Athira Pharma, Inc.
ATHA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $20,874 | $19,888 | $26,422 | $48,438 |
| Short-Term Investments | $4,352 | $9,935 | $10,248 | $2,837 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,799 | $2,395 | $3,183 | $3,566 |
| Total Curr. Assets | $27,025 | $32,218 | $39,853 | $54,841 |
| Property Plant & Equip (Net) | $2,322 | $2,634 | $2,944 | $3,252 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $631 | $631 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $55 | $62 | $716 | $686 |
| Total NC Assets | $3,008 | $3,327 | $3,660 | $3,938 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30,033 | $35,545 | $43,513 | $58,779 |
| Liabilities | – | – | – | – |
| Payables | $266 | $171 | $867 | $319 |
| Short-Term Debt | $452 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,560 | $1,248 | $867 | $2,990 |
| Total Curr. Liab. | $2,787 | $2,981 | $5,492 | $13,135 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $460 | $578 | $691 | $803 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1,017 | $1,117 | $1,217 |
| Total Liabilities | $3,247 | $3,559 | $6,183 | $13,938 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $4 | $4 |
| Retained Earnings | -$428,866 | -$422,255 | -$415,289 | -$406,146 |
| AOCI | -$2 | -$3 | -$4 | $1 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $26,786 | $31,986 | $37,330 | $44,841 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $30,033 | $35,545 | $43,513 | $58,779 |
| Net Debt | -$20,422 | -$19,888 | -$26,422 | -$48,438 |